Each year in U.S. hospitals staph infection kills more than 30,000 patients. A new vaccine able to prevent most of the infections.
American researchers have created a new experimental vaccine that has the ability to protect against staphylococcal infections. Every year they kill tens of thousands of handicapped patients in American hospitals. The study, conducted on mice and rabbits, scientists tested a vaccine against the bacteria Staphylococcus aureus – common microorganisms that live on human skin. They are the main cause of infections of the skin and soft tissues. More than 80% of vaccinated mice survived, while they have a 6-fold increase in the overall cleansing of the body from infection, compared to those who did not pass through a vaccine.
Among rabbits two-thirds of the animals from the immunized group cleared the infection, whereas the group of those who have not received the vaccine, this could not be done to anyone. The authors of the vaccine by scientists from the University of Maryland in Baltimore. Drug targets for biofilm – substance in chronic Staphylococcus aureus developing resistance to the antibodies secreted by the immune system or antibiotics.
Staphylococcus aureus is a common type of bacteria that commonly cause poisoning, blood infection like abscesses and respiratory infections, including sinusitis. A large part of the staphylococcal infection is not life-threatening, but they can enter the bloodstream, triggering sepsis, severe pneumonia, infections of bones and joints. Special risk these bacteria pose to patients in hospitals who already have a weakened immune system.